- Home
- CRNX vs FICO Comparison
CRNX vs FICO Comparison
Compare CRNX & FICO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRNX | FICO |
|---|---|---|
| Founded | 2008 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 41.2B |
| IPO Year | 2018 | 1987 |
Fundamental Metrics
Financial Performance| Metric | CRNX | FICO |
|---|---|---|
| Price | $49.41 | $1,817.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 13 |
| Target Price | $71.00 | ★ $2,050.69 |
| AVG Volume (30 Days) | ★ 1.1M | 171.1K |
| Earning Date | 11-06-2025 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.78 |
| EPS | N/A | ★ 26.54 |
| Revenue | $1,535,000.00 | ★ $1,990,869,000.00 |
| Revenue This Year | $425.31 | $24.77 |
| Revenue Next Year | $943.50 | $17.55 |
| P/E Ratio | ★ N/A | $69.52 |
| Revenue Growth | ★ 47.74 | 15.91 |
| 52 Week Low | $24.10 | $1,300.00 |
| 52 Week High | $60.25 | $2,217.60 |
Technical Indicators
Market Signals| Indicator | CRNX | FICO |
|---|---|---|
| Relative Strength Index (RSI) | 65.11 | 58.01 |
| Support Level | $46.49 | $1,724.43 |
| Resistance Level | $50.98 | $1,858.91 |
| Average True Range (ATR) | 1.95 | 46.74 |
| MACD | 0.35 | 0.73 |
| Stochastic Oscillator | 78.51 | 68.72 |
Price Performance
Historical ComparisonAbout CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About FICO Fair Isaac Corproation
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.